key: cord-0799678-trynmc6e
authors: Zargaran, Alexander; Zargaran, David; Masterton, Gary; Mosahebi, Afshin
title: Consent, decision-making and operative planning in plastic surgery during the COVID-19 pandemic
date: 2020-11-08
journal: J Plast Reconstr Aesthet Surg
DOI: 10.1016/j.bjps.2020.10.102
sha: 6da7222534ed0198e147b7ffb3525d75ae2f1335
doc_id: 799678
cord_uid: trynmc6e

Decision-making, consent and operative planning within plastic surgery demand increased consideration during the COVID-19 pandemic. Discourse surrounding material risk to patients undergoing procedures in both the peri-operative and post-operative periods will result in more informed decision-making by patients. The local NHS region reproductive (R) rate will form an important component of this discussion. Furthermore, given the challenges to healthcare services, a more joined-up-approach is fundamental involving the patient, plastic surgeon and wider hospital services to ensure that there is sufficient capacity and resource to manage increased patient throughput. Technology including virtual and e-consenting may enhance and facilitate this process for both patients and surgeons.

operative periods will result in more informed decision-making by patients. The local NHS region reproductive (R) rate will form an important component of this discussion. Furthermore, given the challenges to healthcare services, a more joinedup-approach is fundamental involving the patient, plastic surgeon and wider hospital services to ensure that there is sufficient capacity and resource to manage increased patient throughput. Technology including virtual and e-consenting may enhance and facilitate this process for both patients and surgeons.

The General Medical Council set out updated guidance effective from November 2020 highlighting the importance of consent and decision making(1). Traditionally, consent relies upon a capacitous individual having a conversation with the healthcare professional and receiving information that includes a discussion pertaining to the associated risks and benefits of the procedure. The COVID-19 pandemic has precipitated a paradigm shift in medical workflows, mitigating risks of SARS-CoV-2, and with regards to consent, we need to develop a dynamic and more fluid process whereby patients' legal and ethical rights are safeguarded through appropriate consideration of material risks. With the recovery of surgical services initiative, particularly within plastic surgery, consideration must be given to consent, Therefore, we feel it is important that within the consent process, local variations in prevalence of SARS-CoV-2 are explained to patients, and perhaps the latest local R rate for the local NHS region should be quoted as standard practice, with an explanation of the possibility of increased risks to patients undergoing plastic surgery. Furthermore, on a hospital level, consideration should also be given to local Intensive Care Unit capacity, given the known increased risk of 30-day-mortality and pulmonary complications arising from SARS-CoV-2 infection in surgical patients.

This will necessitate a joined-up-approach towards consent and decision making, between the patient, the plastic surgeon, and other hospital services to ensure that both the patient, and the surgical team make informed decisions regarding the riskbenefit trade-off and best course of action for the patient. 

Appellant) v Lanarkshire Health Board (Respondent) (Scotland)

The R number and growth rate in the UK -GOV.UK [Internet

St Andrew's COVID-19 surgery safety (StACS) study: Elective plastic surgery, trauma & burns

Surgical Guidelines During COVID-19 from the SAGES Video Library